MENU
EBS
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Emergent Biosolutions (EBS) Ownership - Who owns Emergent Biosolutions?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
300 Professional Drive
Phone
+1 240 631-3200
Employees
1600
Web
https://www.emergentbiosolutions.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
120.07M
P/E Ratio
17.73
Total Cash
111.7M
Projected Growth
N/A
Total Debt
860.2M
Revenue
1.02B
Risk (Beta)
1.25
Dividend Yield
N/A
Total Cash/Share
2.14
Total Debt/Equity
52.57
Revenue/Share
19.98 USD as % of share price
Fundamentals
EBS
Capitalization
120M
P/E Ratio
17.73
Risk (Beta)
1.25
Dividend Yield
N/A
Total Cash
112M
Total Cash/Share
2.14
Total Debt
860M
Total Debt/Equity
52.57
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
19.98%
Revenue
1.02B
ROE
N/A
Book Value
649M
P/B Ratio
0.18
Cash Flow
N/A
Earnings
-14.85
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
100K
Current Ratio
1.04
Current Revenue Per Employee
168687.50
Dividends Per Share - Security
N/A
EBITDA
-518.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
31.42
Revenue To Assets
-30.48
Shares Held By Institutions
171M
Shares Outstanding - Current
52.2M
Total Liabilities
1.17B
Total Volume MTD
N/A
Value
N/A
Gain YTD
286.250
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of biopharmaceutical products
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
Biotechnology
Address
300 Professional Drive
Phone
+1 240 631-3200
Employees
1600
Web
https://www.emergentbiosolutions.com